Skip Navigation


NDT Advance Access originally published online on July 27, 2004
Nephrology Dialysis Transplantation 2004 19(10):2570-2575; doi:10.1093/ndt/gfh415
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/10/2570    most recent
gfh415v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wanner, C.
Right arrow Articles by Passlick-Deetjen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wanner, C.
Right arrow Articles by Passlick-Deetjen, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant Vol. 19 No. 10 © ERA-EDTA 2004; all rights reserved


Original Article

Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients

Christoph Wanner1, Udo Bahner2, Renate Mattern1, Dietmar Lang3 and Jutta Passlick-Deetjen3

1 Department of Medicine, Division of Nephrology, University Clinic of Würzburg, Würzburg, 2 Kuratorium für Dialyse und Nierentransplantation, Würzburg and 3 Fresenius Medical Care, Bad Homburg, Germany

Correspondence and offprint requests to: Christoph Wanner, MD, Department of Medicine, Division of Nephrology, University Hospital, Josef-Schneider-Strasse 2, D-97080 Wuerzburg, Germany. Email: wanner_c{at}klinik.uni-wuerzburg.de

Background. Dyslipidaemia, inflammation and oxidative stress are prominent risk factors that potentially cause vascular disease in haemodialysis patients. Dialysis modalities affect uraemic dyslipidaemia, possibly by modifying oxidative stress, but the effects of dialyser flux and membrane material on atherogenic remnant particles and oxidized low-density lipoproteins (LDL) are unknown.

Methods. We performed a randomized crossover study in 36 patients on haemodialysis to analyse the effect of dialyser flux and membrane material on plasma lipids, apolipoproteins and markers of inflammation and oxidative stress. Stable patients on low-flux dialysis with polysulphone for ≥6 weeks were assigned to high-flux polysulphone or high-flux modified cellulose with similar dialyser surface area and permeability characteristics and crossed over twice every 6 weeks.

Results. Thirty patients completed the study per protocol. Treatments with high-flux polysulphone and modified cellulose lowered serum triglyceride (by 20% and 10%, respectively; P<0.05) and remnant-like particle cholesterol by 32% (P<0.001) and 11% (NS) after the first 6 weeks of treatment. Oxidized LDL decreased significantly with high-flux polysulphone, but not with modified cellulose. Apolipoproteins CII and CIII were reduced, whereas the ratio CII/CIII was increased (all P<0.05). Acute-phase proteins and LDL and high-density lipoprotein cholesterol remained unaffected.

Conclusions. This randomized crossover study demonstrates a potent effect of high-flux haemodialysis on uraemic dyslipidaemia. Polysulphone membrane material showed superiority on oxidatively modified LDL, an indicator of oxidative stress in haemodialysis patients.

Keywords: acute-phase proteins; apolipoproteins; high-flux haemodialysis; lipids; oxidative stress; polysulphone


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. Panzetta, C. Basile, A. Santoro, E. Ancarani, S. Costantini, F. Guarnieri, and G. Verzetti
Diabetics on dialysis in Italy: a nationwide epidemiological study
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3988 - 3995.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Galli
Protein damage and inflammation in uraemia and dialysis patients
Nephrol. Dial. Transplant., July 1, 2007; 22(suppl_5): v20 - v36.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. C.H. Kwan, F. Kronenberg, S. Beddhu, and A. K. Cheung
Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1246 - 1261.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.